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Abstract
The intramitocondrial localization of the phosphate-activated glutaminase from Ehrlich cells has been examined by a
combination of techniques, including: mitochondria subfractionation studies, chemical modification with sulfhydryl group
reagents of different permeability, enzymatic digestion in both sides of the inner mitochondrial membrane, and immunologi-
cal studies. Using alkaline extraction at high ionic strength, hypoosmotic shock and freezing–thawing cycle techniques, the
enzyme was found in the particulate fraction. On the contrary, glutaminase activity was labile when subfractionation was
carried out by digitoninrlubrol method; Western blot analysis localized the inactive enzyme in the matrix fraction. In
addition, glutaminase was fully inactivated when mitoplasts were incubated with phospholipase A and phospholipase C.2
The enzyme also showed a non-linear Arrhenius plot with a break at 248C. The membrane-impermeant thiol reagents
mersalyl and p-chloromercuriphenylsulfonic acid do not inhibit glutaminase activity in freeze–thawed mitochondria and
mitoplasts, but N-ethylmaleimide, which is membrane permeant, strongly inhibited the enzyme. However, mersalyl and
p-chloromercuriphenylsulfonic acid were effective inhibitors when the alkylation was performed on the matrix side of
mitoplasts or using detergent-solubilized enzyme. Furthermore, trypsin digestion of mitoplasts was only effective inactivat-
ing glutaminase when the proteolysis was carried out on the matrix side of the vesicles. Enzyme-linked immunosorbent
assay of the soluble and membrane fractions obtained in the preparation of submitochondrial particles, revealed that most of
the enzyme was solubilized, but in the inactive form. Phase separation with Triton X-114 rendered most of the protein in the
aqueous phase. These results taken together discard a transmembrane localization for the protein, whereas they are
consistent with anchorage of glutaminase on the matrix side of the inner mitochondrial membrane, the matrix portion of the
enzyme being relevant for its function.
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Abbreviations: BAEE, N-benzoyl-L-arginine ethyl ester; GDH, glutamate dehydrogenase; GSH, reduced glutathione; GSSG, oxidized
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mercuriphenylsulfonic acid; POEE, polyoxyethylene ether W-1; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered
saline; SDS, sodium dodecyl sulfate; SMP, submitochondrial particles; TPCK, N-tosyl-L-phenylalanine chloromethyl ketone; TX-100,
Triton X-100; TX-114, Triton X-114
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1. Introduction
Mitochondrial phosphate-activated glutaminase
 .PAG; EC 3.5.1.2 catalyses the first step in the
degradation of glutamine, an essential substrate for
energy and nitrogen metabolism of rapidly dividing
w xcells and tumours 1,2 . PAG activity has been corre-
lated with malignancy and growth rate in tumours
w xand proliferating tissues 3–5 .
In higher organisms, PAG appears as two isoen-
zymes, named liver and kidney types. The liver
isoenzyme is only expressed in adult liver whereas
the kidney isoenzyme is present in all other tissues
with glutaminase activity, including kidney, brain,
w xsmall intestine and fetal liver 6 . The complete cDNA
for the rat kidney enzyme and about half of the rat
w xliver isoenzyme have been recently cloned 7,8 . The
only tumour PAG isolated in a highly purified form,
w xthe PAG from Ehrlich ascitic tumour cells 9 , has
kinetic and immunological characteristics similar to
the kidney-type isoenzyme, although it also showed
w xquite different molecular properties 9,10 .
Even though mammalian PAG isoenzymes have
w xbeen purified from several tissues 11–13 and char-
acterized with regard to kinetic and molecular proper-
w xties 6 , the submitochondrial localization of PAG has
been a matter of controversy. Previous studies on
kidney PAG have reported that the enzyme is located
w xin the matrix region 14 , matrix side of the inner
 . w xmitochondrial membrane IMM 15 and in both
halves of the IMM, existing two populations of PAG:
 .one oriented in the intermembrane space c-side ; the
 . w xother in the matrix space m-side 16 . More re-
w xcently, Kvamme et al. 17 have suggested a predomi-
nant c-side localization for the pig kidney isoenzyme,
based on the inactivation by non-permeant SH-re-
agents and the lack of mixing between the
glutamine-derived glutamate and the endogenous ma-
trix glutamate. The studies conducted on the liver
isoenzyme localization are scarce, but the lack of
enzyme release after repeated freezing–thawing cy-
cles, the observation of a break in the Arrhenius plot
of the native enzyme, and solubilization of the PAG
activity after sonication of mitochondria, led to the
hypothesis of a loose association between the enzyme
w xand the IMM 18 .
The assignment of submitochondrial enzyme loca-
tions has also been hampered by the peculiar environ-
ment of the mitochondrial matrix, where high protein
w xconcentrations can be achieved 19 . So, recent stud-
ies have demonstrated that proteins traditionally con-
sidered as soluble matrix enzymes, are instead loosely
associated with the inner face of the IMM; this group
includes tricarboxylic acid cycle, fatty acid oxidation
w xand urea cycle enzymes 20–22 . We approached this
problem by a combination of different techniques:
physical and chemical disruption of the mitochondria,
alkylation with SH-reagents, protein and lipid enzy-
matic digestions and immunological studies. Conver-
gent arguments from these independent topography
experiments indicate that Ehrlich ascites cell PAG
does not behave as a typical integral membrane pro-
tein, but is anchored in the m-side of the IMM; the
matrix portion of the enzyme seems to be a function-
ally sensitive domain. The involvement of the native
lipid environment on the PAG activity was also
investigated.
2. Materials and methods
2.1. Ehrlich ascites cells
A hyperdiploid Lettre strain of Ehrlich ascites cells´
was maintained in 2-month-old female albino Swiss
 . w xmice OF1 SPF Ico , as described elsewhere 23 .
The life span of the animals after inoculation with
5P106 tumour cells was 16"1 days.
2.2. Subfractionation of mitochondria and PAG solu-
bilization
Ascites-tumour-cell mitochondria were isolated es-
w xsentially as described 5 and suspended at 30 mgrml
in 20 mM Tris, 210 mM mannitol, 70 mM sucrose, 1
 .  .mM EGTA pH 8.0 buffer A . Mitochondria sub-
fractionation was performed using the original method
w xof Greenawalt 24 modified for Ehrlich cell mito-
w xchondria as described elsewhere 25 . Submitochon-
drial particles were prepared as previously described
w x26 . PAG solubilization with TX-100 was performed
w xas previously reported 9 . The TX-100
mitochondria-free extract was used immediately and
is referred to as soluble PAG.
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2.3. Phospholipase treatment of mitoplasts
 .Mitoplasts inner membrane plus matrix at 5
mgrml protein concentration were treated with dif-
ferent amounts of phospholipase A or phospholipase2
C for 30 min at 308C. The assay buffer for phospholi-
pase A contained 20 mM Tris, 210 mM mannitol,2
 .70 mM sucrose, 0.32 M NH SO , 1 mM CaCl4 2 4 2
 .pH 8.0 . Phospholipase C digestions were done at
similar conditions but with final concentrations of
 .0.16 M NH SO and 7 mM CaCl . Both reactions4 2 4 2
were stopped by the addition of 10 mM EDTA. PAG
activity was measured immediately in both suspen-
sions, as well as in parallel control samples not
treated with phospholipases.
2.4. Trypsin proteolysis
Trypsin digestions were carried out on both sides
of the IMM. For the c-side digestion, mitoplasts were
 .resuspended 2 mgrml in buffer A, and incubated at
 .258C with TPCK-treated trypsin Worthington .
Trypsin was added externally up to a total of 1:50
 .wrw enzymermitoplasts ratio, during the 18-h in-
cubation period with gentle shaking. The reaction
was stopped by adding trypsin inhibitor in a 1:100
 .wrw trypsinrinhibitor ratio. For the m-side diges-
tion, trypsin was trapped inside the mitoplasts follow-
w xing the general methodology outlined before 27 .
 .Mitoplasts vesicles 2 mg were loaded with trypsin
by rapidly freezing a sample in liquid nitrogen con-
 .taining 100 ml of mitoplasts and solid trypsin 1 mg
in buffer A and slowly thawing the sample on an ice
bath. Two more freezing–thawing cycles were prac-
tised. Extravesicular trypsin was removed by a 40-fold
dilution of the suspension with ice-cold buffer A and
centrifuging at 50 000 rpm in a Beckman type SW-60
rotor for 1 min at 08C. The pellet was resuspended
and centrifuged as above two more times. The final
pellet was resuspended in 500 ml of buffer A and
incubated at 258C for 18 h. Parallel control vesicles
were treated without trypsin. After incubation, the
c-side and m-side digests were immediately assayed
for PAG activity.
2.5. Alkylation with SH-reagents
Freeze–thawed mitochondria, mitoplasts or soluble
PAG were incubated with different concentrations of
thiol reagents added from concentrated aqueous stock
.solutions for 5 min at 258C. Reactions were stopped
with a 200-fold molar excess of b-mercaptoethanol
and immediately assayed for PAG activity. Alkyla-
tion on the m-side of mitoplasts was achieved by
trapping mersalyl and PCMPS at 0.1 and 0.5 mM,
respectively, by freezing–thawing cycles as described
above. These concentrations had no effect on the
PAG activity of mitoplasts when c-side alkylation
was performed. The vesicles were incubated for 12
min at 258C, quenched with a 200-fold molar excess
of b-mercaptoethanol and assayed for PAG activity.
2.6. Antibody production and purification
PAG was purified and polyclonal antibodies ob-
w xtained as described elsewhere 9 . An IgG fraction
was also affinity purified against the 72 kDa glutami-
nase band; these antibodies specifically recognize the
Ehrlich carcinoma glutaminase protein by im-
munoblot analyses in both purified preparations and
w xfrozen mitochondria 9 . Western blotting was carried
w xout essentially as described previously 28 . Samples
were subjected to SDS-PAGE and then transferred to
nitrocellulose. Protein standards were located on
nitrocellulose by staining with amido black. Immuno-
detection with affinity purified anti-glutaminase anti-
bodies was carried out with a biotin-avidin peroxi-
dase kit Vectastain ABC kit; Vector Labs,
. w xBurlingame, CA as reported previously 9 .
2.7. Antibody assay by enzyme-linked immunosorbent
( )assay ELISA
Submitochondrial particles and the soluble fraction
obtained in the preparation of these particles were
diluted with a buffer consisting of 10 mM Tris, 0.12
 .M KCl, and 1 mM EDTA pH 7.3 , to obtain the
optimal working dilutions; 200 ml of the samples
were added to each well of the ELISA plates Im-
.mulon-2 . After coating by overnight incubation at
48C, the wells were washed with PBS and blocked
with 1% BSA solution in PBS for 1 h at room
temperature. After washing with PBS supplemented
 .  .with 0.05% wrv Tween-20 PBS-T , the plate was
incubated at room temperature for 2 h with 200 ml of
affinity purified IgG diluted in PBS-T. The plate was
washed with PBS-T, and 200 ml of a solution of
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peroxidase-conjugated anti-rabbit IgG diluted 1000-
fold with PBS-T was added to each well and incu-
bated for 2 h at room temperature. Then, they were
washed and filled with a solution of 5 mgrml o-di-
 .anisidine in 20 mM potassium phosphate pH 6
supplemented with 15 mM H O . After 1 h in the2 2
dark at room temperature, the peroxidase reaction
was stopped by addition of 20 ml of 2 M H SO .2 4
The absorbance of the samples was followed at 450
 .nm with a 2001 microplate reader Whittaker .
2.8. Phase separation with TX-114
The detergent TX-114 was precondensed essen-
w xtially as described 29 . Freeze–thawed mitochondria
or mitoplasts were resuspended at 4 mgrml in 10
 .mM Tris, 150 mM NaCl pH 7.4 . Then, 1 ml of this
suspension was cooled at 08C and supplemented with
 .10 mM pepstatin, 10 mM leupeptin and 0.9% wrv
TX-114. After centrifugation at 13 000=g for 5 min
at 48C, the clear supernatant was transferred to a cold
microfuge tube and centrifuged again at 13 000=g
for 25 min at 48C. The supernatant was employed for
w xphase separation according to 29 , including the
 .reextraction of both phases aqueous and detergent .
The final detergent and aqueous phases were incu-
 .bated with 10% trichloroacetic acid TCA at 08C for
1 h. The protein pellets were washed with 10% TCA
and with cold acetone before being submitted for
SDS-PAGE and Western blotting. PAG activity and
protein content were also measured in an aliquot of
both phases before TCA precipitation.
2.9. Enzyme and protein assays
PAG activity was measured by a stopped assay as
w xdescribed elsewhere 10 . For subfractionation stud-
ies, the following marker activities were measured as
w x previously reported 25 : adenylate kinase EC
.2.7.4.3 for the outer membrane plus intermembrane
 .space; citrate synthase EC 4.1.3.7 for the matrix
 .fraction; and cytochrome c oxidase EC 1.9.3.1 for
the inner mitochondrial membrane. To assess the
relative membrane permeability of the thiol reagents
employed, the matrix content of glutathione was de-
termined in the absence or presence of the indicated
amounts of alkylating reagents, following the method
w xof Griffith 30 .
For evaluation of the trypsin trapped inside the
mitoplasts by freezing–thawing cycles, trypsin activ-
ity was measured using N-benzoyl-L-arginine ethyl
 . ester BAEE as substrate one BAEE unitsD A253
y3 .of 10 per min at pH 7.6 and 258C . Mitoplasts
were supplemented with 37 500 BAEE units of
trypsin. After freezing–thawing cycles, washing and
incubation, the mitoplasts were sonicated and trypsin
activity determined. About 1.5% of the initial trypsin
was trapped inside the mitoplasts. Protein concentra-
tions were determined by a method recommended for
w xmembrane proteins 31 , using BSA as a standard.
SDS-PAGE was performed as described elsewhere
w x9 . Apparent molecular masses of proteins were de-
termined by using the Low-Molecular-Weight Cali-
bration Kit of Pharmacia, containing: phosphorylase
 .  .  .b 94 kDa , BSA 67 kDa , ovalbumin 43 kDa ,
 . carbonic anhydrase 30 kDa , trypsin inhibitor 20.1
.  .kDa , and a-lactalbumin 14.4 kDa .
3. Results
3.1. Effect of alkylating SH-reagents on PAG acti˝ity
Initial experiments for PAG localization seemed to
indicate that the enzyme is somehow attached to the
inner mitochondrial membrane, since a different
number of treatments for washing and stripping pe-
ripheral proteins, including alkaline extraction at pH
9.5 in the presence of high ionic strength 0.5 M
.KCl , hypoosmotic shock and freezing–thawing cy-
cles, failed to release PAG from mitoplasts; the bulk
of the activity was always found in the pellet fraction
 .after high-speed centrifugation results not shown .
Furthermore, a markedly different inhibition pattern
of PAG activity was observed with the SH-reagents
 .NEM, mersalyl and PCMPS Table 1 , when soluble
or particulate enzyme was used. In the particulate
fractions, mitochondria and mitoplasts, NEM strongly
inhibited PAG activity but almost no effect was
detected with mersalyl and PCMPS. The inhibition
by NEM was concentration dependent in the range of
 .0–1 mM results not shown . The concentration range
used for these reagents was similar to those normally
w xemployed in enzyme inhibition studies 17,32 . More-
over, the differences found cannot be ascribed to the
different concentrations of thiol-reagents used, be-
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Table 1
Effect of thiol reagents on PAG activity in membrane-bound and
soluble forms
Reagent Percentage of PAG activity versus control
mitochondria mitoplasts soluble
None 100.0 100.0 100.0
NEM 1 mM 24.9"7.9 5.1"1.4 2.0"1.2
Mersalyl 0.1 mM 95.1"3.1 87.7"1.2 1.0"0.7
PCMPS 0.5 mM 88.0"3.0 97.8"1.7 2.5"1.2
Samples were incubated in the presence of the indicated concen-
trations of reagents for 5 min at 258C. Reactions were quenched
with b-mercaptoethanol and immediately assayed for PAG activ-
ity. Values are expressed as means"S.E. of at least three differ-
ent experiments. Hundred per cent values in nmolrmg
proteinrmin were 136"9, 126"11, and 111"13, for mitochon-
dria, mitoplasts and solubilized enzyme, respectively.
cause similar results were obtained by increasing the
concentrations of mersalyl and PCMPS to 1 mM not
.shown . However, at the same concentrations, mer-
salyl and PCMPS, as well as NEM, were very effec-
 .tive inhibitors of the soluble PAG Table 1 .
Even though NEM is generally referred to as a
membrane-permeant reagent whereas mersalyl and
PCMPS have been reported to be essentially mem-
w xbrane-impermeant 33 , it was necessary to establish
the permeability of these reagents in our system
 . Table 2 . Mitochondrial glutathione content GSH
.plus GSSG was chosen as an indicator of the sul-
fydryl reagent permeability. NEM drastically de-
creased the matrix glutathione levels, which seems to
confirm its permeability through the inner mitochon-
drial membrane of Ehrlich mitochondria. On the other
Table 2
 .Glutathione content reduced and oxidized forms of the Ehrlich
mitocondrial matrix after treatment with thiol reagents
w xReagent GSHqGSSG %
 .nmolrmg protein
None 6.0 100
NEM 0.2 mM 3.9 65
NEM 1.0 mM 1.2 20
Mersalyl 0.1 mM 5.5 92
PCMPS 0.5 mM 5.3 88
After incubation with the SH-reagents, mitochondria were
quenched with 20 mM b-mercaptoethanol and washed twice with
buffer A. Samples were then processed for glutathione content as
w xdescribed by Griffith 30 . Values are means of two different
determinations in duplicate.
Table 3
Effect of the permeability barrier afforded by the inner membrane




Mersalyl 0.1 mM 130"14 80"15
PCMPS 0.5 mM 116" 2 68"16
 .Thiol reagents were trapped inside the mitoplasts m-side or
 .added exogenously c-side , as outlined in Section 2. Values are
means"S.E. of at least three different experiments.
a Units of specific activity: nmolrmg proteinrmin.
hand, the matrix glutathione content slightly de-
creased with mersalyl and PCMPS at the concentra-
tions employed in the chemical modification experi-
ments, providing further evidence that they are mem-
brane-impermeable reagents. However, when the per-
meability barrier was suppressed by trapping mer-
salyl and PCMPS inside the mitoplasts by freezing–
thawing cycles, both reagents clearly inhibited PAG
 .activity Table 3 . This inhibition actually reflected
alkylation of the PAG protein, as judged by the fact
that reversal of the inhibition was not observed after
solubilization of the mitoplasts with TX-100 not
.shown .
3.2. Subfractionation of Ehrlich mitochondria
To remove the outer membrane and to obtain the
mitoplast fraction, Ehrlich mitochondria needed a
significant lower concentration of digitonin compared
w xwith rat liver mitochondria 24 , due to its high
w xcholesterol concentration 34 . After subfractionation
of mitoplasts with the detergent POEE, the recovery
of various marker enzymatic activities assayed to
assess the purity of the different mitochondrial frac-
tions was very satisfactory, with values always higher
w xthan 90% 25 . However, most of the PAG activity
 .88.6% of the initial was labile under the conditions
used for subfractionation. Although the PAG activity
was lost, it was possible to detect the protein with
w xaffinity purified antibodies against PAG 9 . Western
blot of the different fractions obtained during mito-
chondrial subfractionation revealed that the inactive
PAG protein mostly appeared in the matrix fraction
 .Fig. 1, lane 3 ; a slight immunoreactivity is observed
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Fig. 1. Immunoblot analysis of PAG after submitochondrial
fractionation with detergents. Ehrlich mitochondria were fraction-
ated with digitoninrlubrol and the various fractions subjected to
SDS-PAGE and Western blotting. The blot was revealed using
immunopurified anti-Ehrlich PAG antibodies. Lane 1, inner mito-
chondrial membrane; lane 2, outer membrane plus intermembrane
space; lane 3, mitochondrial matrix. The upper band corresponds
to the 72 kDa glutaminase protein; other degradation products
 .appear as low molecular mass bands 65–61 kDa . Equal amounts
of protein were applied to each lane.
in the outer membrane plus intermembrane space
 .fraction Fig. 1, lane 2 . PAG appears as the 72 kDa
protein band; lower peptide bands of 65 kDa and 61
kDa also arose, due to the proteolysis of the 72 kDa
w xband 9 .
3.3. Phase separation by TX-114
When Ehrlich mitochondria were analysed by
phase separation using the detergent TX-114, PAG
did not retain biological activity; only a residual
activity was found in the aqueous phase. The phase
separation of hydrophilic and amphiphilic proteins
achieved is shown in Fig. 2, which represents a
typical Coomassie-stained SDS-gel of the detergent
and aqueous phases. Western blotting of both phases
with purified anti-PAG antibodies detected the 72
kDa glutaminase band on the detergent-poor aqueous
 .phase Fig. 3 ; several low molecular mass bands
were also detected, corresponding to proteolytic
degradation products, an unavoidable effect when
using particulate fractions or initial purification steps
of PAG, due to the strong susceptibility to proteolytic
w xattack shown by this enzyme 9 .
3.4. ELISA of submitochondrial particles
We also studied the distribution of PAG in sub-
mitochondrial fractions obtained in the absence of
detergents by a standard sonication procedure. Under
these conditions, most of the citrate synthase activity
 .85–90% was released to the soluble fraction ob-
tained after high-speed centrifugation of the sonicated
sample. Data of ELISA test of submitochondrial par-
 .ticles SMP are presented in Fig. 4, and show that
the binding of immunopurified anti-PAG antibodies
was preferentially found in the soluble fraction and
 .not in the particulate fraction SMP . These results
rule out a transmembrane orientation of the protein,
but would seem to indicate that PAG behaves as a
matrix enzyme. Interestingly, about 25% of the signal
 .is still found on the SMP fraction Fig. 4 . The
specificity of the immunoreaction was demonstrated
Fig. 2. SDS-PAGE pattern of mitochondrial proteins after phase-
separation with TX-114. Ehrlich mitochondria were solubilized
with the detergent TX-114 and subjected to phase-separation at
308C as described in Section 2. Aliquots of both phases in SDS
sample buffer with b-mercaptoethanol were analysed by SDS-
PAGE and the gel stained with Coomassie blue R-250. Lane D,
detergent phase; lane A, aqueous phase; lane S, standard molecu-
lar mass markers, from top to bottom: 94, 67, 43, and 30 kDa.
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Fig. 3. Western blot of PAG after TX-114 phase-separation of
Ehrlich mitochondria. The detergent and aqueous phases obtained
were subjected to SDS-PAGE, transferred to nitrocellulose, and
immunostained. The blot was revealed with immunopurified
anti-Ehrlich PAG antibodies. Lane A, aqueous phase; lane D,
detergent phase. The arrow indicates the position of the 72 kDa
glutaminase band.
by using non-immune serum, BSA and plasma mem-
 .brane vesicles from Ehrlich cells not shown as
controls. The PAG enzymatic activity was completely
lost after the sonication procedure needed to generate
SMP particles; it was already undetectable in the
crude sample before centrifugation and after separa-
tion of the SMP and soluble fractions.
3.5. Phospholipase digestions
The effect of phospholipase treatment on mitoplast
PAG activity was also investigated. Although the
molecular masses of phospholipase A and C prevent2
them from penetrating the bilayer, the incubations
necessary to carry out these experiments may lead to
degradation of lipids exposed at both sides of the
membrane. In any case, the data shown in Fig. 5
clearly suggest that complete inactivation of PAG can
be achieved upon treatment of the inner mitochon-
Fig. 4. Distribution of the PAG protein after submitochondrial
particles formation assessed by ELISA. A mitochondrial suspen-
sion was sonicated and this crude sample was separated by
 .centrifugation in a pellet fraction submitochondrial particles and
a soluble fraction. Microtitre plates were coated with working
 .dilutions of these samples 2–5 mg proteinrml . Then, they were
incubated with diluted immunopurified anti-PAG antibodies.
Binding of antibodies was detected by a chromogenic reaction
 .cf. Section 2 . A 100 mgrml BSA solution was used as a
control. Plotted data in ordinate represent values of absorbance at
450 nm. Black boxes, nonimmune control serum. Hatched boxes,
anti-PAG antibodies. Four different assays were performed; a
typical experiment is depicted.
Fig. 5. PAG inactivation by phospholipases. Mitoplasts were
incubated for 30 min at pH 8.0 with different concentrations of
 .  .phospholipase A v or phospholipase C ‘ , in the presence2
of optimal Ca2q concentration. The reactions were stopped with
EDTA and PAG activity immediately assayed.
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Fig. 6. Arrhenius plot of PAG activity in freeze–thawed mito-
chondria. Thermal equilibration of the mitoplasts with the media
was achieved by 5-min preincubation period at the experimental
temperature. The incubation time for measuring PAG activity
was shortened to 5 min, to assure that a linear reaction rate was
maintained over the whole temperature interval. The lines and
break point were determined by linear regression least-squares
analyses of the experimental data. The apparent activation ener-
gies obtained are 72.1 kJrmol below 248C and 32.7 kJrmol
above 248C.
drial membrane with phospholipase A and C; these2
results seem difficult to reconcile with a truly matrix
localization of the enzyme in the mitochondria.
3.6. Arrhenius plot of the enzyme
Another approach used to examine the relationship
of PAG activity to membrane environment was to
determine the effects of temperature perturbation of
Table 4




 .y Trypsin 103"7 103"2
 .q Trypsin 104"6 45"8
 .Inactivation % 0 56.3
 .Trypsin was added externally to the mitoplasts c-side or trapped
 .inside m-side , as described in Section 2. About 700"194
BAEE trypsin units were trapped inside the vesicles. Results are
expressed as means"S.E. of at least three different determina-
tions.
a Units of specific activity: nmolrmg proteinrmin.
the inner membrane on PAG activity. Arrhenius plot
for mitoplasts could be resolved into two linear seg-
ments, with heat-inactivation occurring above 408C
 .Fig. 6 . The plot showed a break point at 248C,
which allows us to calculate two activation energies
for the glutaminase reaction: 72.1 kJrmol for tem-
peratures between 108C and 248C, 32.7 kJrmol for
the 24–378C temperature range. It is noteworthy that
a linear Arrhenius plot was obtained when TX-100
 .was added to the mitoplasts results not shown ;
moreover, the Arrhenius plot for the soluble and
highly purified form of the enzyme showed no such
w xdiscontinuity 35 .
3.7. Trypsin proteolysis
Further investigation of the topography of PAG
within the inner mitochondrial membrane was carried
out by means of enzymatic digestions of the protein
with trypsin. The experimental design was based on a
selective attack of PAG from each half of the inner
 .membrane; proteolysis from the outer leaflet c-side
was achieved by incubating sealed mitoplasts with
externally added trypsin, whereas proteolysis from
 .the inner leaflet m-side was performed by internally
trapping the trypsin. It was carefully checked that no
trypsin leakage occurred during the digestion. As can
be seen in Table 4, PAG was not inactivated at all
when mitoplasts were treated with externally added
trypsin. In contrast, more than half of the enzyme
activity was lost when proteolysis was performed on
the m-side of the vesicles. Therefore, it appears that
PAG does not have a c-side domain or, at least, it is
not functionally sensitive, whereas it seems clear that
the protein has a m-side domain and proteolysis of
this region has a deleterious effect on activity.
4. Discussion
The topography of PAG in the mitochondria is an
important issue which has profound physiological
implications in tumour cells, since they have a high
glutaminolysis related to the operativity of glutamine,
glutamate and phosphate carriers.
The experiments of chemical modification showed
that the enzyme was only inactivated by NEM in
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 .membrane fractions mitochondria and mitoplasts ,
whereas mersalyl and PCMPS failed to do so; how-
ever, they inactivated PAG in a soluble form or when
the reagent was trapped inside the vesicles. The inner
membrane acts as a permeability barrier so the mem-
 .brane-impermeant reagents mersalyl and PCMPS
cannot reach PAG. Thus, it can be deduced that PAG
has functionally-sensitive cysteine residues in the
m-side of the IMM. Although NEM is widely ac-
cepted as membrane-permeant and mersalyl and
w xPCMPS as membrane-impermeant reagents 33 , ex-
w xceptions have also been found 17 . Given the aim of
the present work, it is advisable to thoroughly ascer-
tain their degree of permeability; this was correlated
with the ability to decrease the matrix glutathione
content. While mersalyl and PCMPS had a negligible
effect, NEM almost exhausted the mitochondrial glu-
tathione. The conclusion is that the inner membrane
 .becomes a barrier to access to essential residue s in
PAG.
With regard to glutaminases, only partial inhibition
 .40–60% by 1 mM NEM was detected in pig renal
mitochondrial and rat brain synaptosomal glutami-
w xnases 17,36 . In contrast, the rat liver enzyme was
w xcompletely inactivated by NEM 37 . Recently, a
counteraction of TX-100 on the partial NEM inhibi-
w xtion of pig kidney PAG has been reported 17 . A
detergent-promoted conformational change, turning
the protein insensitive to the bound sulfhydryl reagent,
was suggested to occur. However, our results are not
consistent with any counteraction of TX-100 on the
NEM inactivation. Moreover, after membrane solubi-
lization with TX-100 the inhibition was maintained
and soluble PAG was also effectively inhibited by
NEM. On the other hand, the data support that im-
pairment of PAG activity caused by NEM is not due
to an indirect effect on mitochondrial carriers, since
the glutamine carrier was insensitive to NEM in
w xEhrlich cells 25 and preincubation of mitochondria
with an excess of phosphate did not prevent the
inhibition of glutamine hydrolysis.
Submitochondrial fractionation under conditions
which yields highly pure mitochondrial fractions, in-
w xactivated the enzyme 25 ; however, immunoblot
analysis clearly demonstrated that most of the en-
zyme partitioned in the matrix fraction. This result
discards an association of the enzyme with the outer
membrane or the intermembrane space; in addition, it
strongly indicates that PAG does not behave as an
integral protein under our subfractionation condi-
tions, 96.7% of the cytochrome c oxidase activity
.was found in the IMM fraction . However, two possi-
bilities remain: PAG can be a peripheral protein
associated with the IMM or, alternatively, a truly
matrix-soluble enzyme. The method of subfractiona-
 .tion digitoninrlubrol could result in desorption of a
peripheral protein, and then inactivation after loosing
its anchor to the IMM. This hypothesis is in good
agreement with the results reported for b-hydroxy-
butyrate dehydrogenase, a peripheral enzyme an-
w xchored to the m-side of the IMM 38 and also
w xinactivated by the detergent lubrol 39 .
Integral and peripheral proteins can be easily sepa-
rated by phase-separation using the detergent TX-114
w x29 . When mitochondria or mitoplasts were fraction-
ated, a markedly different pattern of peptide bands
was detected in each phase, but PAG activity was lost
again; after analysis by Western blot the PAG
polypeptide mostly appeared on the detergent-poor
aqueous phase, where peripheral and soluble species
w xare almost always found 40 . Peripheral proteins are
anchored to membranes mainly by ionic interactions
with the polar groups of lipids andror proteins;
however, a few of them, like b-hydroxybutyrate de-
hydrogenase, also displays many features of hy-
w xdrophobic interactions 38 . It is important to keep in
mind that stripping of the IMM with alkaline extrac-
tion at high ionic strength failed to release PAG. Not
all the proteins that are anchored to bilayers via ionic
interactions can be removed with salt. Cations do not
w xpromote desorption of spectrin 41 , myelin basic
w x w xprotein 42 and polymyxin 43 ; these may be an
example of proteins that interact with membranes in
w xtwo ways: electrostatically and hydrophobically 38 .
In any case, the extreme instability of the enzyme
after fractionation with TX-114 points out toward
some kind of association with the inner membrane,
which is essential for activity.
 .In submitochondrial particles SMP prepared by
controlled sonication, the PAG activity was unde-
tectable in the two fractions obtained soluble and
.SMP , but immunological assays by ELISA yielded
clear-cut results: most of the protein was specifically
found in the soluble fraction. Sonication has been
reported to solubilize the rat liver enzyme without
w xsignificantly affecting its activity 13,44 ; on the con-
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trary, in Ehrlich tumour cell mitochondria sonication
inactivates PAG and treatment with detergents was
the most effective procedure for enzyme solubiliza-
tion, although prolonged exposure to TX-100 had a
w xdeleterious effect on the enzyme stability 9 . This
result might indicate that the detergent strips away
the annular lipids of the enzyme, since TX-100 is a
w xstrong delipidating detergent 45 . In rat kidney mito-
chondria, solubilization of PAG also requires 10-fold
greater concentrations of various detergents than
w xneeded to release soluble matrix activities 12 .
If PAG is associated to the inner membrane, struc-
tural perturbation or fluidity changes of the bilayer
should elicit alterations in PAG activity. Enzymatic
digestions of lipids with either phospholipase A or2
C, completely abolished PAG activity. Phospholipid
hydrolysis could result in the disruption of function-
ally important lipid–protein interactions necessary for
proper enzyme function. The same result was ob-
served with two phospholipases yielding different
products lysophospholipids and fatty acids on one
.hand, diglycerides on the other , which strongly sup-
ports that the ultimate reasons for enzyme inactiva-
tion are the loss of intact phospholipid and the lipid
rearrangement caused by the lipolytic products men-
w xtioned 46 . It is noteworthy that rat liver PAG can be
effectively solubilized from mitochondria by treat-
ment with phospholipase A , with 88% of the total2
w xactivity recovered in soluble form 47 ; the same
authors concluded that enzyme kinetics are modu-
lated by interactions with membrane phospholipids.
A break of linearity in the Arrhenius plot of an
enzyme can be attributed to several causes, one of
them being lipid phase separation occurring within
w xthe bilayer 45 . Not only integral proteins show this
behavior; peripheral enzymes, like b-hydroxy-
butyrate dehydrogenase, also presented a break at
around 208C which was abolished after mitochondria
w xsolubilization 39 . For Ehrlich PAG the discontinuity
also disappeared when detergent was added or when
a highly purified form of the enzyme was used; so,
the discontinuity in the Arrhenius plot may indicate a
phase change in the lipids affecting PAG activity. A
similar break for the rat kidney enzyme was at-
tributed to a conformational change of the mem-
brane-bound protein; it was related to alterations in
the phospholipid layer and not to diffusional limita-
tions of the supply of substrate or effectors, because
the same break was obtained in mitochondria dis-
rupted with 0.04% TX-100, a concentration which
w xdid not detach PAG from the membrane 48 . Fur-
thermore, a discontinuity at 238C for the rat liver
enzyme was also argued to support attachment of the
w xenzyme to the inner membrane 18 .
By hydropathy analysis of the rat kidney enzyme,
it was shown that the protein lacks a membrane-span-
w xning domain 7 ; however, mammary glutaminases
also showed a notorious hydrophobic character. Thus,
attempts to electrophorese these enzymes in standard
native PAGE systems failed because they irreversibly
w xaggregated and precipitated 44,49 ; only after inclu-
sion of CHAPS or TX-100 in the PAGE systems
w xwere these proteins satisfactorily resolved 49 . In
addition, purified Ehrlich PAG was strongly bound to
phenyl-Superose, which is used to retain highly hy-
w xdrophobic proteins 50 ; moreover, elution was only
achieved after complete removal of the salt gradient
w x9 . Recently, a hydrophobic association of rat kidney
PAG with other inner membrane enzymes has been
postulated, based on the presence of two contiguous
w xtryptophan residues in the protein sequence 51 . A
very attractive hypothesis would be the association of
PAG with the mitochondrial glutamine carrier as a
channelling mechanism; some early experimental data
suggested that glutamine is not released into the
matrix but rather delivered directly to glutaminase
w x52 . Alternatively, PAG might be also part of the
w xmitochondrial transport system for glutamine 53 .
However, the IMM vesicles obtained by
digitoninrlubrol showed a very active L-glutamine
w xtransport activity 25 although they were devoid of
 .PAG protein this work . So, in Ehrlich mitochondria
we conclude that both activities belong to different
proteins, although we cannot rule out the possibility
w xof a physical interaction between them 54 .
Apart from the submitochondrial location, another
physiologically relevant issue is the orientation of the
enzyme in the membrane. Proteolytic digestions with
trypsin on both sides of the inner membrane strongly
suggest a m-side location for Ehrlich PAG, discard-
ing a transmembrane topography of the enzyme. Our
results strongly support that most of the
functionally-sensitive domain of Ehrlich PAG is lo-
cated on the m-side of the membrane, and do not
agree with the orientation reported for the pig kidney
 .enzyme, where a main external location c-side was
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w xpostulated 17 . Although species- or tissue-specific
differences cannot be discarded, this location will
pose several questions, the main one would be the
necessity for very active mitochondrial glutamine
carriers, as those reported for rat kidney and tumour
w xcells 55,25 . On the other hand, PAG is involved in
different key functions in each tissue; in kidney, a
predominant c-side location on the IMM might have
physiological sense, because it would facilitate the
release of ammonium ions on the cytosol during
increased renal ammoniagenesis avoiding toxic ef-
w xfects of ammonia on respiratory chain function 17 .
5. Concluding remarks
The above exposed experimental evidence sup-
ports several issues concerning PAG topography on
 .the inner mitochondrial membrane. 1 The Ehrlich
ascites tumour cell PAG is not an integral membrane
 .protein. 2 The enzyme is peripheral and located in
 .the inner leaflet m-side of the IMM, in the mem-
 .brane–water interface. 3 Not only ionic interactions
seem to hold the enzyme anchored to the membrane,
but hydrophobic interactions with not yet identified
lipid or proteins of the IMM are also likely to be
 .involved. 4 The mitochondrial glutamine carrier and
 .PAG belong to different proteins. 5 The lipid envi-
ronment of the protein may be important in regulat-
ing PAG activity, perturbations of its native mem-
 .brane domain inactivated the enzyme. 6 The protein
has its functionally relevant domain in the matrix
space, and some thiol groups that would be essential
for PAG activity are located in the matrix andror
buried into the IMM. The question of which are the
components of the mitochondrial membrane interact-
ing with PAG remains unanswered at present and
will require further investigation.
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